Summary The President of Opko’s key BioReference division (82.8% of 2016 revenue) resigned and no new successor was named. We believe this to be a strong negative omen.  A recent lawsuit filed against BioReference alleges violations of law including forgery, releasing unverified test results, and falsification of employee training & competency documents.  A pattern of